Answers are grounded in this paper and cite their sources.
The outcome for adult patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) remains poor; new chemotherapy agents with activity against these leukemias are urgently need...
No takes yet. Share an insight, caveat, or question.
Wartman et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: